1 |
2 × 106/ml |
Human |
Silylated chitosan and cellulose hydrogel |
Canine OC defect in dogs |
Boyer et al. (2020)
|
2 |
0.02 × 106 cells/spheroid |
Human |
3D-printed osteochondral interface using osteogenic and chondrogenic spheroid |
In vitro study |
Ayan et al. (2020)
|
3 |
0.5 × 106 cell/40 ml |
Rabbit |
Porous poly (ε-caprolactone) (PCL) scaffold with different pore sizes |
OC defect in femur of rabbit |
Im et al. (2012)
|
4 |
0.2 × 106 cells/350 μl |
Human |
3D collagen gel scaffold |
In vitro study |
Scioli et al. (2016)
|
5 |
1 × 107 cells/ml |
Rabbit |
Coacervate-embedded composite hydrogels |
Femoral trochlear osteochondral defect in rabbit |
Cho et al. (2020)
|
6 |
0.25 × 106/cm2 (when 0% tricalcium phosphate used) and 0.02 × 106/cm2 (when 20% TCP used) |
Human |
Stacked polylactic acid nanofibrous scaffolds |
In vitro study |
Mellor et al. (2015)
|
7 |
1 × 107 cells/ml |
Human |
Cancellous bone/hydrogel (chitosan/gelatin) hybrid scaffold |
In vitro study |
Song et al. (2016)
|
8 |
2 × 106 cells |
Rabbit |
Cartilage extracellular matrix-derived particles (CEDPs) and cartilage slice-based scaffold |
Rabbit femoral trochlear osteochondral defect |
Yin et al. (2018)
|
9 |
0.4 × 106 cells/30 ul |
Human immortalized ASCs (Evercyte, Cat# CHT-001-0005) |
Photo-crosslinked gelatin methacryloyl (gelMA) scaffold |
In vitro study |
Hölzl et al. (2021)
|
10 |
0.256 × 106 per microspheroids |
Human immortalized ASCs (Evercyte, Cat# CHT-001-0005) |
Gelatin-based hydrogels |
In vitro study |
Zigon-Branc et al. (2019)
|
11 |
0.25 × 106 cells for the chondrogenic layer and 0.5 × 106 cells for the osteogenic layer |
Rabbit |
Trilayered silk fibroin scaffolds |
In vitro study |
Ding et al. (2014)
|
12 |
0.25 × 106 cells/scaffold |
Human |
Multiphasic 3D-bioplotted scaffolds |
In vitro study |
Mellor et al. (2020)
|
13 |
2 × 106 cells/scaffold |
Rabbit |
Biodegradable porous sponge cartilage scaffold |
Full thickness femoral defect in rabbits |
Widhiyanto et al. (2020)
|
14 |
0.5 × 106 cells/ml (in vivo) 5 × 103 cells/ml–0.5 × 106 cells/ml (in vitro) |
Not specified |
Protein-reactive nanofibrils scaffold |
Articular cartilage defect |
Kim et al. (2021)
|
15 |
50 ul of 50 × 106 cells/ml |
Rabbit |
Poly(L-glutamic acid)-based scaffold |
Articular osteochondral defect in rabbits |
Zhang et al. (2016)
|
16 |
3 × 106 cells |
Minipig human |
Oligo (polyethylene glycol) fumarate (OPF) hydrogel |
OC defect in minipigs |
De Girolamo et al. (2015)
|
17 |
0.5 × 106 cells |
Rabbit |
Immobilized porous polycaprolactone scaffold |
Distal femur OC defect in rabbits |
Im and Lee, (2010)
|
18 |
0.25 × 106 co-cultured cells with human articular chondrocytes |
Human immortalized ASCs (Evercyte, Cat# CHT-001-0005) |
AuriScaff (auricular cartilage scaffold) |
OC plug model in mice |
Nürnberger et al. (2019)
|
19 |
0.075 × 106 and 0.15 × 106 cells |
Pig ASCs |
Multiphasic 3D-bioplotted scaffold |
OC defects in minipigs |
Nordberg et al. (2021)
|